abstract |
The present invention is in the field of medicinal chemistry. in particular, the invention relates to a morita-baylis-hillman adduct, which functions as a cell-cell inhibitor, apoptosis inducer and k + channel activator in oncogene cell, and its use in cancer therapy and treatment. other associated diseases. |